Nordic CLL Study Group Logo
  • Trials
  • Events and meetings
  • Organization and committees
    • Bylaws
    • Members
  • Nordic CLL Study Centers
    • Denmark
    • Finland
    • Norway
    • Sweden
    • Iceland
  • Links
  • Contact
  • Menu

Trials

Ongoing trials:

Gaia/CLL13 –  clinicaltrials.gov

CLL17 – https://www.dcllsg.de/en/trial/cll17/index.php

DCLLSG | CLL-RT1 Trial – Phase-II trial to evaluate the efficacy and safety of zanubrutinib (BGB-3111), a BTK inhibitor, plus tislelizumab (BGB-A317), a PD1 inhibitor, for treatment of patients with Richter Transformation .

PreVent ACaLL – clinicaltrials.gov

Finished awaiting results:

Vision/HO141 – clinicaltrials.gov

CLL 14 –  clinicaltrials.gov